Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population-Reference-Cited by-同舟云学术

Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population

Author:

Jorge April¹^ORCID,McCormick Natalie²^ORCID,Lu Na²,Zheng Yufei³,Esdaile John³,De Vera Mary⁴^ORCID,Choi Hyon¹^ORCID,Aviña‐Zubieta J. Antonio⁴^ORCID

Affiliation:

1. Massachusetts General Hospital Boston Massachusetts

2. Massachusetts General Hospital, Boston, Massachusetts, and Arthritis Research Canada Richmond British Columbia Canada

3. Arthritis Research Canada Richmond British Columbia Canada

4. Arthritis Research Canada, Richmond, and University of British Columbia Vancouver British Columbia Canada

Funder

Canadian Institutes of Health Research

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Michael Smith Foundation for Health Research

Rheumatology Research Foundation

Publisher

Wiley

Subject

Rheumatology

Link

Reference15 articles.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimalarial medications;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Prognosis and mortality of systemic lupus erythematosus;Dubois' Lupus Erythematosus and Related Syndromes;2025